Volume 53, Issue 4, Pages (April 2008)

Slides:

Advertisements

Similar presentations

Volume 62, Issue 4, Pages (October 2012)

Advertisements

The PSA Era is not Over for Prostate Cancer

Volume 68, Issue 2, Pages (August 2015)

Volume 68, Issue 6, Pages (December 2015)

Volume 70, Issue 5, Pages (November 2016)

Volume 57, Issue 1, Pages (January 2010)

Volume 52, Issue 1, Pages (July 2007)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 59, Issue 1, Pages (January 2011)

Testosterone Therapy in Men With Prostate Cancer

Volume 61, Issue 6, Pages (June 2012)

Volume 53, Issue 4, Pages (April 2008)

The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks Marcus G.

Volume 70, Issue 1, Pages (July 2016)

Volume 72, Issue 5, Pages (November 2017)

Volume 61, Issue 5, Pages (May 2012)

Volume 73, Issue 6, Pages (June 2018)

Volume 51, Issue 4, Pages (April 2007)

Prostate Cancer Epidemic in Sight?

Volume 65, Issue 6, Pages (June 2014)

Volume 61, Issue 3, Pages (March 2012)

Volume 63, Issue 4, Pages (April 2013)

Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer Sam Ladjevardi, Gabriel Sandblom,

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 9, Issue 5, Pages (May 2008)

Volume 54, Issue 4, Pages (October 2008)

Elizabeth K. Bancroft, Rosalind A. Eeles

Prostate Cancer Detection: A View of the Future

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Volume 54, Issue 5, Pages (November 2008)

Volume 68, Issue 3, Pages (September 2015)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Prostate Cancer Epidemic in Sight?

James N. Armitage, Stuart O. Irving, Neil A. Burgess European Urology

The PSA Era is not Over for Prostate Cancer

Yuanshan Cui, Yong Zhang European Urology

Volume 74, Issue 3, Pages (September 2018)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 61, Issue 6, Pages (June 2012)

Leonard S. Marks, Jiaoti Huang European Urology

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 71, Issue 1, Pages (January 2017)

Volume 65, Issue 6, Pages (June 2014)

Volume 68, Issue 4, Pages (October 2015)

Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels

Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic.

Volume 50, Issue 5, Pages (November 2006)

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 55, Issue 3, Pages (March 2009)

Volume 71, Issue 3, Pages (March 2017)

Testicular Cancer Variations in Time and Space in Europe

Volume 72, Issue 5, Pages (November 2017)

Volume 59, Issue 4, Pages (April 2011)

Volume 71, Issue 4, Pages (April 2017)

Volume 15, Issue 10, Pages (September 2014)

European Urology is “Your” Journal

Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg

Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

Volume 74, Issue 6, Pages (December 2018)

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

The Comparability of Models for Predicting the Risk of a Positive Prostate Biopsy with Prostate-Specific Antigen Alone: A Systematic Review Fritz Schröder,

Volume 52, Issue 6, Pages (December 2007)

Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel Daniel A. Leongamornlert,

Volume 68, Issue 2, Pages (August 2015)

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Volume 53, Issue 2, Pages (February 2008)

Systematic Review of Complications of Prostate Biopsy

Volume 74, Issue 6, Pages (December 2018)

Volume 52, Issue 5, Pages (November 2007)

Presentation transcript:

Volume 53, Issue 4, Pages 777-784 (April 2008) Contribution of a Single Repeat PSA Test to Prostate Cancer Risk Assessment: Experience from the ProtecT Study Derek J. Rosario, J. Athene Lane, Chris Metcalfe, James W. Catto, Daniel Dedman, Jenny L. Donovan, David E. Neal, Freddie C. Hamdy European Urology Volume 53, Issue 4, Pages 777-784 (April 2008) DOI: 10.1016/j.eururo.2007.11.064 Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 1 Consort diagram for cohort studied. PSA=prostate-specific antigen. European Urology 2008 53, 777-784DOI: (10.1016/j.eururo.2007.11.064) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 2 Comparison of the four prostate-specific antigen (PSA) measures using area under the receiver operating characteristic curve for all cancers (A) and high-grade cancer (B). ROC=receiver operating characteristic; CI=confidence interval. European Urology 2008 53, 777-784DOI: (10.1016/j.eururo.2007.11.064) Copyright © 2007 European Association of Urology Terms and Conditions